(Q42961660)

11 November 2017

title

Characterization of clonal strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Ontario, Canada (English)

1 reference

11 November 2017

0 references

0 references

Pseudomonas aeruginosa

1 reference

2

1 reference

11 November 2017

Trevor Beaudoin

1

1 reference

11 November 2017

Tracy Giesbrecht-Lewis

series ordinal

3

1 reference

11 November 2017

Kathy Vandemheen

series ordinal

4

1 reference

11 November 2017

Thien-Fah Mah

series ordinal

5

1 reference

11 November 2017

publication date

1 July 2010

1 reference

Canadian Journal of Microbiology

11 November 2017

published in

1 reference

11 November 2017

volume

56

1 reference

11 November 2017

issue

7

1 reference

11 November 2017

page(s)

548-557

1 reference

Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa

11 November 2017

cites work

1 reference

A longitudinal assessment of the effect of inhaled fluticasone propionate therapy on adrenal function and growth in young children with asthma

21 January 2018

1 reference

Epidemiological investigation and glycotyping of clinical Pseudomonas aeruginosa isolates from patients with cystic fibrosis by mass spectrometry: association with multiple drug resistance

21 January 2018

1 reference

Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics

21 January 2018

1 reference

Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa

21 January 2018

1 reference

Determinants of mortality from cystic fibrosis in Canada, 1970-1989.

21 January 2018

1 reference

Bacterial biofilms: a common cause of persistent infections

21 January 2018

1 reference

Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa.

21 January 2018

1 reference

Comparison of maximum specific growth rates and lag times estimated from absorbance and viable count data by different mathematical models

21 January 2018

1 reference

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

21 January 2018

1 reference

Antibiotic susceptibility patterns and clones of Pseudomonas aeruginosa in Swedish ICUs.

21 January 2018

1 reference

Outbreak of resistant Pseudomonas aeruginosa infections during a quarterly cycling antibiotic regimen.

21 January 2018

1 reference

Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa

21 January 2018

1 reference

Epidemics of drug-resistant bacterial infections observed in infectious disease surveillance in Japan, 2001-2005.

21 January 2018

1 reference

Multilocus sequence typing compared to pulsed-field gel electrophoresis for molecular typing of Pseudomonas aeruginosa

21 January 2018

1 reference

mlstdbNet - distributed multi-locus sequence typing (MLST) databases

21 January 2018

1 reference

Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.

21 January 2018

1 reference

Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.

21 January 2018

1 reference

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously

21 January 2018

1 reference

A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance

21 January 2018

1 reference

Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms

21 January 2018

1 reference

Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa

21 January 2018

1 reference

Growing and analyzing static biofilms

21 January 2018

1 reference

Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients

21 January 2018

1 reference

Maximum Likelihood based comparison of the specific growth rates for P. aeruginosa and four mutator strains

21 January 2018

1 reference

Aminoglycoside resistance in Pseudomonas aeruginosa

21 January 2018

1 reference

Two efflux systems expressed simultaneously in multidrug-resistant Pseudomonas aeruginosa

21 January 2018

1 reference

Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms

21 January 2018

1 reference

Contribution of the MexXY Multidrug Transporter to Aminoglycoside Resistance in Pseudomonas aeruginosa Clinical Isolates

21 January 2018

1 reference

Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada.

21 January 2018

1 reference

Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen

21 January 2018

1 reference

Antimicrobial susceptibility and molecular epidemiological analysis of clinical strains of Pseudomonas aeruginosa

21 January 2018

1 reference

Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.

21 January 2018

1 reference

P. aeruginosa Biofilms in CF Infection

21 January 2018

1 reference

Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances

21 January 2018

1 reference

Involvement of a novel efflux system in biofilm-specific resistance to antibiotics

21 January 2018

1 reference

Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1139/W10-043

1 reference

11 November 2017

1 reference